Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Amgen Inc. Revenue & Financial Statements
Amgen Inc. reported revenue of $36.8B for the fiscal year ended December 31, 2025, up 10.0% year over year, with net income of $7.7B and diluted EPS of $14.23.
- Company
- Amgen Inc. AMGN · NASDAQ
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 26.0B | 26.3B | 28.2B | 33.4B | 36.8B |
| Cost of revenue | 6.5B | 6.4B | 8.5B | 12.9B | 12.0B |
| Gross profit | 19.5B | 19.9B | 19.7B | 20.6B | 24.7B |
| Operating income | 7.6B | 9.6B | 7.9B | 7.3B | 9.1B |
| Pretax income | — | — | 3.8B | 569.0M | 756.0M |
| Net income | 6.1B | 7.1B | 6.7B | 4.3B | 7.7B |
| Diluted EPS | 10.28 | 12.11 | 12.49 | 7.56 | 14.23 |
| EBITDA | 11.0B | 13.0B | 12.0B | 12.8B | 14.2B |
Quarterly
| USD | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.4B | 8.4B | 8.5B | 9.1B | 8.1B | 9.2B | 9.6B | 9.9B |
| Cost of revenue | 3.2B | 3.2B | 3.3B | 3.1B | 3.0B | 3.0B | 3.1B | 3.0B |
| Gross profit | 4.2B | 5.2B | 5.2B | 6.0B | 5.2B | 6.2B | 6.5B | 6.9B |
| Operating income | 991.0M | 1.9B | 2.0B | 2.3B | 1.2B | 2.7B | 2.5B | 2.7B |
| Pretax income | — | — | — | — | — | — | — | — |
| Net income | (14.0M) | 781.0M | 2.6B | 897.0M | 1.6B | 1.1B | 3.3B | 1.3B |
| Diluted EPS | -0.21 | 1.38 | 5.22 | 1.16 | 3.20 | 2.65 | 5.93 | 2.46 |
| EBITDA | 2.4B | — | 3.4B | 3.7B | 2.6B | 2.9B | 3.8B | 3.9B |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 61.2B | 65.1B | 97.2B | 91.8B | 90.6B |
| Current assets | 19.4B | 22.2B | 30.3B | 29.0B | 29.1B |
| Cash & equivalents | 8.0B | 7.6B | 10.9B | 12.0B | 9.1B |
| Total liabilities | — | — | — | — | — |
| Current liabilities | 12.2B | 15.7B | 18.4B | 23.1B | 25.5B |
| Long-term debt | 33.2B | 37.4B | 63.2B | 56.5B | 50.0B |
| Total debt | 33.3B | 38.9B | 64.6B | 60.1B | 54.6B |
| Stockholders’ equity | 6.7B | 3.7B | 6.2B | 5.9B | 8.7B |
| Net debt | 25.3B | 31.3B | 53.7B | 48.1B | 45.5B |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 9.3B | 9.7B | 8.5B | 11.5B | 10.0B |
| Investing cash flow | 733.0M | (6.0B) | (26.2B) | (1.0B) | (1.9B) |
| Financing cash flow | (8.3B) | (4.0B) | 21.0B | (9.4B) | (10.9B) |
| Capital expenditure | 880.0M | 936.0M | 1.1B | 1.1B | 1.9B |
| Free cash flow | 8.4B | 8.8B | 7.4B | 10.4B | 8.1B |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 341.0M | 401.0M | 431.0M | 530.0M | 494.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every AMGN filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.